We would love to hear your thoughts about our site and services, please take our survey here.
Would you kindly give us the source of this update?
There is nothing on SEDAR.
How many more years will we have to wait and will I live long enough?
I would love them to develop a drug to help me live longer.......150 years would do very nicely.
Is there no info about other clients of CIC Capital and CIC Securitization?
Might I suggest we all turn off our mobile phones and computers and go for a walk in the countryside and listen to the birds and bees and learn how to see the beauty all around us?
Thanks Ian,
We are always interested to know whom bloggers are and needed to confirm you were MACNAI. Hence I used Anthony.
We like shareholder activism and not worried what is said unless its a denigration of the obligations directors in the CIC Group.
Kind Regards,
Stuart J. Bromley
Mobile Global +44 (0)731 1400014
www.CICCapital.com
www.Securitisation.com
19-25, Rue des Capucins, L-1313 Luxembourg
linkedin
Email from Stuart
Dear Anthony, (my name is Ian)
Please see attached Innomed Tech Ltd updated prospectus filed today.
Prospectus filing dates are very flexible as significant milestones have are being achieved by management and needs to be included in the prospectus.
These material changes include the following:
1 Advancement of PureFlowCath prototype to near completion
2 Confirmation that PureFlowCath medical device does not require multi year clinical testing as it is an advancement on approved devices (3 year time saving to market)
3 Securitisation parties being finalised. I have attached the parties diagram and you can see CIC is way ahead in its Luxembourg operation vs. any competitors
4 Financial Statements are to 31 March 2022 and do not require updating for nine months. Please note the PureFlowCath medical device IP Financial Statements are separate to what is in the prospectus.
5 All IP has been transferred to CIC Fund Securitisation (refer to extensive list of IP in Prospectus Schedules).
6 No debt with the majority 12 month expenditure prepaid
7 CIC has raised US$ 4.1 million in equity finance since 15 April 2020 (date of CIC take over) delivered to client and reflected in Audited Financial Statements.
8 CIC Fund Securitisation S.A. has delivered first debt finance of Euro 1.1 million with Euro 8.9 m in trust account to be delivered on listing. The initial payment to cover 12 month working capital.
CIC Capital Ltd is now regulated Transaction Advisor in EU, US and Canada. The multi jurisdiction foot print has now attracted multinational corporation requiring specialist securitisation and coupled with Transaction advisory using a single provider - CIC rather that engaging different legal, accounting and other advisors focused in a particular jurisdiction.
Please contact my mobile if you require any further inputs.
Kind Regards,
Stuart J. Bromley
Mobile Global +44 (0)731 1400014
www.CICCapital.com
www.Securitisation.com
19-25, Rue des Capucins, L-1313 Luxembourg
linkedin
Thank you Rob.
Most web sites normally have a link to their new website..
I see that CIC Securitization web site no longer exists. Does that mean that they got what they wanted as in Innomed Tech?
Have they given up on the securitization thing?
Current Web sites..........
https://www.ciccapital.com/
Sedar page for CIC Capital https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00048115
Nothing new there since March 2020
https://www.innomedtec.com/
Sedar page for Innomed https://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00048771
http://www.cicgold.com/
http://www.cicangel.com/index.html (CIC Capital Fund Ltd .....which Stuart seems to own )
http://cicveritas.com/
As far as I know CIC Capital Fund no longer exists and our free shares no longer exist.
https://www.linkedin.com/in/robert-rhodes-9294aa24/?midToken=AQGYVWWrnOexxA&midSig=2GMqZ5vvB7EGc1&trk=eml-email_pymk_02-pymk-28-prof%7Ephoto&trkEmail=eml-email_pymk_02-pymk-28-prof%7Ephoto-null-1i0j60%7El213on0h%7E6y-null-neptune%2Fprofile%7Evanity%2Eview
Chief Executive Officer / Executive DirectorChief Executive Officer / Executive Director
InnoMed Tech Ltd · Full-timeInnoMed Tech Ltd · Full-time
Mar 2020 - Present · 2 yrs 2 mosMar 2020 - Present · 2 yrs 2 mos
Vancouver, British Columbia, CanadaVancouver, British Columbia, Canada
InnoMed Tech Ltd is the holding company for multiple subsidiary companies working with members of the global medical and scientific community and its team of legal, scientific and financial advisors to develop innovative medical and science products.InnoMed Tech Ltd is the holding company for multiple subsidiary companies working with members of the global medical and scientific community and its team of legal, scientific and financial advisors to develop innovative medical and science products.
What other companies are working with CIC Capital.
They must be more.
This was posted by Sparty1 on ADVFN.
Corporate update received. Regarding listing and patent approval news.. small snippit..
"Summary of Operations
InnoMed Tech Ltd. is?pleased to provide an update on some of the corporate activities and outcomes since the last update on December 16, 2021, and AGM on March 8, 2022.
The Company has begun receiving equity investment inquiries from professional investors and specialist medical technology funds. Any transactions required to be undertaken would be within the strict requirements of the Company’s governance framework, including where necessary, the consultation and approval of existing shareholders.
TSX Venture Exchange Listing Update
The Company’s prospectus review by the regulator remains largely completed, save updating the financial statements. The Company is required to complete, post March 31 2022, audited financial statements to December 31, 2021, and interim financial statement for March 31, 2022 (Q1). On receipt of the audited financial statements for the year ended December 31, 2021 from the Auditor and completion of the interim audited financial statements, the Company will be in a position to then file the updated financial statements in the prospectus for final approval and the listing application on the TSX Venture Exchange. The next review application is expected to be filed before end of April 2022. "
Preliminary Long Form Prospectus. See for yourself on Innomed web site.
https://www.innomedtec.com/copy-of-about
Ian,
Travelling at present.
Your shares in Innomed Tech Ltd is now registered and held electronically. When it gets closer to listing we will then inform you.
Please in the mean time see attched the latest prospectus.
Kind Regards
Stuart J. Bromley
I have had no info concerning free Innomed shares from Kevin or Stuart since the AGM.
Offering free shares of a company does not seem the right thing for a company to be doing that aims to list on a stock. market.
I think that CIC Gold is a dead duck. They never actually owned the Mongolian property and I cannot see Stuart tramping around in the Mongolian desert. The board of directors are getting too old for that soart of thing.
Hopefully, we will get more info from Stuart or Kevin after 8th March.
Form of Proxy - Annual General & Special Meeting to be held on March 8, 2022
Ordinary Business
1. To receive and consider the audited consolidated financial statements of the Corporation for the 12-month periods
ended 31 December 2020 together with the report of the directors and auditors thereon.
2. To elect directors and determine the number of directors at five (5) in accordance with the Corporations’s
articles of association.
3. To appoint auditors and to authorise the directors to fix their remuneration.
8. To transact such further or other business as may properly come before the Meeting or any adjournment or adjournments
thereof.
Form of Proxy - Annual General & Special Meeting to be held on March 8, 2022
Please email Proxy form to: Bromley@CICCapital.com
Please email on or before March 6, 2022
Name Age Position Appointment
Terrence Larkan 60 Chairmans /CFO March 23, 2020
Robert L. Rhodes 63 CEO / Executive Director March 23, 2020
Dr Marshall K. Walker MD 40 Non-Executive Director March 23, 2020
David Toyoda 54 Non-Executive Director July 1, 2020
Billy R. Williams 43 Non-Executive Director March 1, 2021
4. To adopt, by special resolution, the new Articles of Incorporation.
5. All previous acts and deeds, of the Board of Directors of the Corporation is hereby confirmed, ratified and approved
thereof.
6. To authorise the award of 500,000 warrants to each Director including subsidiary Directors.
7. To approve the transfer of all patents and patent applications to CIC Fund Securitisation S.A. to secure debt financ
up to Euro 90,000,000, and further authorise all deeds and acts related to the securitisation transaction
8. To transact such further or other business as may properly come before the Meeting or any adjournment or adjournments
Some posts have gone missing.
Have the Russians hacked LSE
The catheters would need to be manufactured and tested using the 10 million Euros so far raised using the patents as security.
Had no contact with Kevin.
All these deals are to create a false market in Innomed shares just like what happened to CIC Gold except they never came through with deals to keep the pot boiling and CIC Gold withered away.
Same shares.........just the first out of the hat I presume. Hopefully, they are all still alive.
Some of us are going to need the new catheters before long.
My dad had a long-term catheter and suffered terribly from bladder infections.
"CIC has issued same dividend to another 159 CIC Fund shareholders whereby they have agreed to buy the 5 share on the market for every dividend share."
Who are the 159 shareholders and do any of them post here?
159 + 22 = 181 so they are still short of the 200 needed for the float.
By the way, I am supposed to receive 50K free shares and I hope they won't ask me to buy 5 shares at 29 cents for each free share
Hopefully, Stuart will weave his magic so that all CIC shareholders will be happy after a successful float of Innomed.
Innomed Tech also had to pay US$120,000 of the CIC Fund transaction as there was a lot of individual agreement involved and setting up their share register etc..
Please feel free to share this insight to CIC Funds client share establishment if you so desire.
Kind Regards
Stuart J. Bromley
Thanks for your email,
We only selected a 22 CIC share holders to receive dividend shares in Innomed tech. CIC will buy on the market 5 shares for every share issued as a dividend to these 22 shareholder, you are one. This is detailed in the YE 2020 Audited Financial Statements Item 8.
"Shares Issued for No Consideration
During the year ended December 31, 2020, the Company issued 6,927,826 common shares to certain individual and institutional investors for no consideration, but these investors are required to purchase 5 common shares on the market for each common share issued to them when the Company is listed on a designated exchange. The shares issued were recorded at fair value, with corresponding increase in deficit. The fair value of the shares was based on most recent arm’s length financing transactions."
Please note from Innomed Tech prospectus Prior Sales section you will note that subscribers have paid US 29 cents per share.
CIC has issued same dividend to another 159 CIC Fund shareholders whereby they have agreed to buy the 5 share on the market for every dividend share.
You getting some deep insight as to the value of having my mobile number public as we have built since 2002 a known professional investor base. This has come from really hard work where I take calls all hours and answer emails as soon as received (in most cases).
CIC Capital Ltd always operates as a regulated Canadian entity and as such CIC management complies with National Policy 51-201 Disclosure Standards which requires only one person to communicate with shareholders (Disclosure Officer). So at present, separate from any other function I am the nominated Disclosure Officer.
In June 2015 when CIC Gold listed as a shell, it traded at 5 to 7 pence, 32 million shares per month (1/3 of its issued capital). Placing CIC Gold as the highest traded by volume to issued capital company on the London Stock Exchange bar non. This was a result from shares issued as a dividend with buying on the market requirement as described above. By market cap CIC Gold was worth GBP 5.57 million. The reason why we pulled it from main market I will detail in future.
This dividend model is highly valued by clients for the following reasons:
1 Provides a required shareholder base by exchanges. For TSX it is 200 shareholders with a minimum of 500 share each.
2 We deliver pension funds and professional investors with minimal retail investors. Retail investors if aligned to CIC with a deep understanding of how the Company operates and how the board makes decisions is important for smaller volume sales on the market for the professional investors to pick up. Professional investors generally are in the Long and in the case of medical device companies will wait until the patents and governmental approvals have been achieved.
3 The on buying in the market requirement side steps the high risk of relying on broker and market makers to affect high distribution.